Results 211 to 220 of about 995,492 (287)

Precision palliative care in advanced/recurrent esophageal cancer patients treated with anti-PD-1/PD-L1 immunotherapy (ESO-Shanghai 25): a randomized, phase III Trial. [PDF]

Future Oncol
Hao S, Wang X, Ding H, Chen Y, Liu Q, Zhang J, Fan X, Wu Z, Lin Y, Xu X, Mao G, Ai D, Deng J, Zhu H, Ye J, Mo M, Hu Z, Wang H, Cheng W, Feng W, Ling Y, Xu Y, Du S, Wang J, Zhao K.   +24 more
europepmc   +1 more source

Glycemic Variability and Outcomes in Sepsis: There's No Smoke without Fire! [PDF]

Indian J Crit Care Med
Magoon R.
europepmc   +1 more source

Healthcare Resource Utilisation and Cost of Obesity and Related Complications in the United States: A Systematic Literature Review

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aim Obesity is an increasingly prevalent, chronic, heterogeneous disease, associated with a variety of obesity‐related complications (ORCs). This systematic literature review assessed US healthcare resource utilisation (HCRU) and costs (direct and indirect) for people living with obesity (PwO) or overweight and ORCs.
Jaime P. Almandoz, Jamy D. Ard, Chellse Gazda, Shenelle Edwards‐Hampton   +3 more
wiley   +1 more source

Correction: Opening the black box: defining true-negative outcomes in esophageal cancer screening - a population-based study. [PDF]

BMC Med
Liu M, Yan Z, Liu A, Guo C, Yang H, Li F, Duan L, Shen L, Liu Z, Pan Y, Liu Y, Liu F, Yang W, Tian H, Qi Z, Zhou R, Cai H, Wu Q, He Z, Ke Y.   +19 more
europepmc   +1 more source

Comparison of SGLT2 Inhibitors for New‐Onset Proteinuria Risk in Patients With Type 2 Diabetes and Preserved Kidney Function

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To compare the effects of individual SGLT2 inhibitors on preventing new‐onset proteinuria in patients with type 2 diabetes and preserved kidney function. Materials and Methods A target trial emulation was performed using commercially available databases, including health checkups and claims data, between April 1, 2014 and March 31, 2023 ...
Hiroki Nobayashi, Michihiro Satoh, Takuo Hirose, Shingo Nakayama, Yutaro Iwabe, Hideaki Hashimoto, Takahisa Murakami, Kouji Okada, Takefumi Mori, Hirohito Metoki   +9 more
wiley   +1 more source

L'Estel, núm. 624

, 2008
  +4 more sources

Investigating the mechanism of gastrodin-regulated miR-128-3p in methamphetamine dependence via integrated pharmacology. [PDF]

Medicine (Baltimore)
Li H, He Y, Wu Y, Luo C, Peng Y, Liu W, Li J, Huang Y, Chen R, Ma D, Mo Z.   +10 more
europepmc   +1 more source

A Type 2 Diabetes Policy Model That Predicts Remaining Life Expectancy, Quality‐Adjusted Life Expectancy and Healthcare Costs for Use in Economic Evaluation, Incorporating Equity Concerns

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To illustrate a T2DM policy model incorporating socio‐economic status. Materials and Methods Using the Scottish Diabetes Research Network (SDRN) national diabetes cohort, we identified individuals newly diagnosed with T2DM between 1 January 2004 and 31 December 2020 and followed from diagnosis until death or end of follow‐up.
Lili Wei, Houra Haghpanahan, Sarah H. Wild, Claudia Geue, Elaine Butterly, Peter McMeekin, Stuart McGurnaghan, Luke A. K. Blackbourn, Robert Lindsay, David McAllister, Jim Lewsey   +10 more
wiley   +1 more source

Bayesian teaching enables probabilistic reasoning in large language models. [PDF]

Nat Commun
Qiu L, Sha F, Allen K, Kim Y, Linzen T, van Steenkiste S.   +5 more
europepmc   +1 more source

Success and failure in England's patent system: New evidence from patent applications, 1783–1834

The Economic History Review, EarlyView.
Abstract Our understanding of the relationship between the English patent system and technical change during the industrial revolution is based entirely on the study of successful patents. We address this feature by providing the first study of unsuccessful patent applications in England during the first industrial revolution.
Stephen D. Billington, Joe Lane
wiley   +1 more source